Aop Orphan Pharmaceuticals AG
Records under this name other than the patents Aop Orphan Pharmaceuticals AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 5 of 5 · Back to Aop Orphan Pharmaceuticals AG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,329,254 | Process for the Preparation of 6-Chloro-2,3,4,9-Tetrahydro-1H-CARBAZOLE-1-Carboxamide and Intermediates Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,213,464 | Method for Enhancing Engraftment of Haematopoetic Stem Cells Formerly held In force · High confidence | In force | High confidence | |
| US 10,940,136 | Cannabinoids for prophylactic treatment of involuntary weight loss Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,486,990 | SirT inhibitors that bind to NAD Formerly held Term ended Term ended Nov 20, 2024 · USPTO record | Term ended | Term ended Nov 20, 2024 | USPTO record |
| US 9,782,413 | Composition for treatment of essential thrombocythemia Lapsed on the fee record Ended Oct 10, 2021 · USPTO record | Lapsed on the fee record | Ended Oct 10, 2021 | USPTO record |